Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
YBL108W
REST API REST API
Saccharomyces cerevisiae
YBL108W is differentially expressed in 8 experiments: 2 compound treatments: doxycycline, none;, 2 developmental stages: meiotic development, mitotic growth;, 3 genotypes 6 growth conditions 1 strain background is fy23 x fy86 (winston et al. 1995), carrying the auxotrophic markers
UniProt Accession P38161
Search EB-eye YBL108W
Show more properties
Experimental Factors
Compound treatment

studied in E-GEOD-3200

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.
Factor Value U/D Experiments
doxycycline
1
E-GEOD-3200
none
8
1
E-GEOD-3200


Developmental stage

studied in E-TABM-291

Factor Value U/D Experiments
meiotic development
1
E-TABM-291
mitotic growth
1
E-TABM-291


Genotype

studied in E-GEOD-1639, E-TABM-291, E-MEXP-27

Factor Value U/D Experiments
rpd3Δ
1
E-GEOD-1639
wild_type
1
1
23
E-MEXP-27, E-TABM-291
abf1-1 hypomorph / GAL-ABF1 overexpression transgene
1
E-TABM-291


Growth condition

studied in E-TABM-291, E-MTAB-78, E-MEXP-593

Factor Value U/D Experiments
SPII media
1
E-TABM-291
aerobic
1
1
E-MTAB-78
0.02 vol/h dilution rate
1
E-MEXP-593
0.2 vol/h dilution rate
1
E-MEXP-593
anaerobic
1
E-MTAB-78
YPA media
1
E-TABM-291


Strain Background is FY23 x FY86 (Winston et al. 1995), carrying the auxotrophic markers

studied in E-GEOD-11801

Factor Value U/D Experiments
his3-delta200, leu2-delta1, trp1-delta63, ura3-52. The strain contains deletions in the genes XRN1, RRP6, LSM1, and PAT1.
1
E-GEOD-11801


Processing time: 1.216 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM